Eiju Negoro
Matsuoka, 9101193, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 43 publications
Progressive Multifocal Leukoencephalopathy or Lymphoma? A Massive Unilateral Hemispheric Mimicker in a Patient Undergoing Lymphoma Treatment.
Journal: Reports (MDPI)
Published: April 27, 2026
Optimizing bone health in lymphoma survivors: denosumab superiority to alendronate for R-CHOP-like therapy (the DENOSULY phase III randomized controlled trial).
Journal: Haematologica
Published: January 19, 2026
Impact of the diagnosis-to-treatment interval on the survival of patients with CD5-positive diffuse large B-cell lymphoma.
Journal: Annals of hematology
Published: January 13, 2026
Clinical Impact of the Geriatric Nutritional Risk Index on Chemotherapy-Related Adverse Events in Diffuse Large B-Cell Lymphoma: A Multicenter Study.
Journal: Nutrients
Published: October 16, 2025
Lipidomic profiling of plasma from patients with multiple myeloma receiving bortezomib: an exploratory biomarker study of JCOG1105 (JCOG1105A1).
Journal: Cancer chemotherapy and pharmacology
Published: December 21, 2024
PI3Kδ Inhibitor Parsaclisib in Japanese Patients With Relapsed or Refractory Follicular Lymphoma.
Journal: Cancer science
Published: September 27, 2024
Treatments and Outcomes of Newly Diagnosed CD5-Positive Diffuse Large B-Cell Lymphoma: A Multi-Institutional Observational Study.
Journal: Hematological oncology
Published: August 27, 2024
Japanese subgroup analysis in the Asian phase II study of darinaparsin in patients with relapsed or refractory peripheral T-cell lymphoma.
Journal: Journal of clinical and experimental hematopathology : JCEH
Published: June 28, 2023
Ensitrelvir eradicates persistent SARS-CoV-2 infection in a follicular lymphoma patient treated with anti-CD20 antibodies.
Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
Published: June 05, 2023
Last Updated: 09/26/2026